| 臺大學術典藏 |
2020-10-23T11:54:54Z |
A recently-discovered NMDA receptor gene, GRIN3B, is associated with duration mismatch negativity
|
Lin Y.-T.; Hsieh M.H.; Liu C.-C.; TZUNG-JENG HWANG; Chien Y.-L.; Hwu H.-G.; Liu C.-M. |
| 臺大學術典藏 |
2020-10-23T11:54:53Z |
Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis
|
Liu C.-C.; Hua M.-S.; TZUNG-JENG HWANG; Chiu C.-Y.; Liu C.-M.; Hsieh M.H.; Chien Y.-L.; Lin Y.-T.; Hwu H.-G. |
| 臺大學術典藏 |
2020-10-23T11:54:52Z |
Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis
|
Lin Y.-T.; TZUNG-JENG HWANG; Shan J.-C.; Chiang H.-L.; Sheu Y.-H.; Hwu H.-G. |
| 臺大學術典藏 |
2020-10-23T11:54:50Z |
Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue
|
Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; Lin Y.-T.; Liu C.-M.; TZUNG-JENG HWANG; Hsieh M.H.; Liu C.-C.; Chien Y.-L.; Udawela M.; Gibbons A.S.; Everall I.P.; Hwu H.-G.; Dean B.; Chen W.J. |
| 臺大學術典藏 |
2020-10-23T11:54:48Z |
Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia
|
Wang S.-H.; Hsiao P.-C.; Yeh L.-L.; Liu C.-M.; Liu C.-C.; TZUNG-JENG HWANG; Hsieh M.H.; Chien Y.-L.; Lin Y.-T.; Chandler S.D.; Faraone S.V.; Laird N.; Neale B.; McCarroll S.A.; Glatt S.J.; Tsuang M.T.; Hwu H.-G.; Chen W.J. |
| 臺大學術典藏 |
2020-10-23T11:54:47Z |
Auditory event-related potentials in antipsychotic-free subjects with ultra-high-risk state and first-episode psychosis
|
Hsieh M.H.; Lin Y.-T.; Chien Y.-L.; TZUNG-JENG HWANG; Hwu H.-G.; Liu C.-M.; Liu C.-C. |
| 臺大學術典藏 |
2020-10-23T11:54:47Z |
Shared and distinct alterations of white matter tracts in remitted and nonremitted patients with schizophrenia
|
Huang J.-Y.; Liu C.-M.; TZUNG-JENG HWANG; Chen Y.-J.; Hsu Y.-C.; Hwu H.-G.; Lin Y.-T.; Hsieh M.-H.; Liu C.-C.; Chien Y.-L.; Tseng W.-Y.I. |
| 臺大學術典藏 |
2020-10-23T11:54:46Z |
Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden cases
|
Liu C.-C.;Lin Y.-T.;Liu C.-M.;Hsieh M.H.;Chien Y.-L.;Tzung-Jeng Hwang;Hwu H.-G.; Liu C.-C.; Lin Y.-T.; Liu C.-M.; Hsieh M.H.; Chien Y.-L.; TZUNG-JENG HWANG; Hwu H.-G. |
| 臺大學術典藏 |
2020-10-23T11:54:46Z |
Genetic associations and expression of extra-short isoforms of disrupted-in-schizophrenia 1 in a neurocognitive subgroup of schizophrenia
|
Liu C.-M.;Liu Y.-L.;Hwu H.-G.;Fann C.S.-J.;Yang U.-C.;Hsu P.-C.;Chang C.-C.;Chen W.J.;Tzung-Jeng Hwang;Hsieh M.H.;Liu C.-C.;Chien Y.-L.;Lin Y.-T.;Tsuang M.T.; Liu C.-M.; Liu Y.-L.; Hwu H.-G.; Fann C.S.-J.; Yang U.-C.; Hsu P.-C.; Chang C.-C.; Chen W.J.; TZUNG-JENG HWANG; Hsieh M.H.; Liu C.-C.; Chien Y.-L.; Lin Y.-T.; Tsuang M.T. |
| 臺大學術典藏 |
2020-10-23T11:54:46Z |
Advanced Paternal Age and Early Onset of Schizophrenia in Sporadic Cases: Not Confounded by Parental Polygenic Risk for Schizophrenia
|
Wang S.-H.;Hsiao P.-C.;Yeh L.-L.;Liu C.-M.;Liu C.-C.;Tzung-Jeng Hwang;Hsieh M.H.;Chien Y.-L.;Lin Y.-T.;Huang Y.-T.;Chen C.-Y.;Chandler S.D.;Faraone S.V.;Neale B.;Glatt S.J.;Tsuang M.T.;Hwu H.-G.;Chen W.J.; Wang S.-H.; Hsiao P.-C.; Yeh L.-L.; Liu C.-M.; Liu C.-C.; TZUNG-JENG HWANG; Hsieh M.H.; Chien Y.-L.; Lin Y.-T.; Huang Y.-T.; Chen C.-Y.; Chandler S.D.; Faraone S.V.; Neale B.; Glatt S.J.; Tsuang M.T.; Hwu H.-G.; Chen W.J. |
| 臺大學術典藏 |
2020-10-23T11:54:45Z |
Stigmas toward psychosis-related clinical features among the general public in Taiwan
|
Wang Y.-C.;Lin Y.-T.;Liu C.-M.;Tzung-Jeng Hwang;Hsieh M.H.;Chien Y.-L.;Hwu H.-G.;Liu C.-C.; Wang Y.-C.; Lin Y.-T.; Liu C.-M.; TZUNG-JENG HWANG; Hsieh M.H.; Chien Y.-L.; Hwu H.-G.; Liu C.-C. |
| 臺大學術典藏 |
2020-10-23T11:54:45Z |
Social cognition in schizophrenia: A network-based approach to a Taiwanese version of the Reading the Mind in the Eyes test
|
Li T.-S.;Liu C.-M.;Liu C.-C.;Hsieh M.H.;Lin Y.-T.;Wang E.-N.;Tzung-Jeng Hwang;Chou T.-L.; Li T.-S.; Liu C.-M.; Liu C.-C.; Hsieh M.H.; Lin Y.-T.; Wang E.-N.; TZUNG-JENG HWANG; Chou T.-L. |
| 臺大學術典藏 |
2020-10-06T03:31:13Z |
Esomeprazole-induced Stevens-Johnson syndrome in a patient who underwent nivolumab therapy for advanced lung adenocarcinoma
|
Lin Y.-T.;Yang J.C.-H.;Chia-Yu Chu; Lin Y.-T.; Yang J.C.-H.; CHIA-YU CHU |
| 臺大學術典藏 |
2020-09-30T08:49:29Z |
The relationship between serum fibrosis markers and restrictive ventricular filling in patients with heart failure with reduced ejection fraction: A technetium-99m radionuclide ventriculography study
|
Lin Y.-T.; Lin Y.-H.; Wu X.-M.; Ko C.-L.; Yen R.-F.; Chen Y.-H.; Hsu R.-B.; Lee C.-M.; Wang S.-S.; Chen M.-F.; YEN-WEN WU |
| 臺大學術典藏 |
2020-09-30T08:12:09Z |
The association between glomerular hyperfiltration and left ventricular structure and function in patients with primary aldosteronism
|
Liao M.-T.; Wu X.-M.; Chang C.-C.; Liao C.-W.; Chen Y.-H.; CHING-CHU LU; Lin Y.-T.; Chang Y.-Y.; Hung C.-S.; Lin L.-C.; Lai C.-L.; Lin L.-Y.; Wu V.-C.; Ho Y.-L.; Wu K.-D.; Lin Y.-H.; TAIPAI Study Group |
| 臺大學術典藏 |
2020-09-30T03:22:27Z |
Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy
|
Sun H.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-C.; Hsiao C.-F.; Chiang C.; Huang S.-H.; Lin S.-W.; Chang S.-Y.; Lin Y.-T.; Huang S.-H.;Lin S.-W.;Chang S.-Y.;Lin Y.-T.;Chiang C.;Hsiao C.-F.;Sun H.-Y.;Liu W.-C.;Su Y.-C.;Chien-Ching Hung;Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:16Z |
Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study
|
Huang S.-H.; Lin S.-W.; Chang S.-Y.; Lin Y.-T.; Sun H.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-C.; Huang S.-H.;Lin S.-W.;Chang S.-Y.;Lin Y.-T.;Sun H.-Y.;Liu W.-C.;Su Y.-C.;Chien-Ching Hung;Chang S.-C. |
| 臺大學術典藏 |
2020-09-28T07:04:41Z |
The relation between the degree of left ventricular mass regression and serum potassium level change in patients with primary aldosteronism after adrenalectomy
|
Liao C.-W.; Chen A.; Lin Y.-T.; Chang Y.-Y.; Wang S.-M.; Hung C.-S.; Wu K.-D.; Chueh S.-C.; Lin Y.-H. |
| 臺大學術典藏 |
2020-09-28T07:04:38Z |
Aldosterone induces tissue inhibitor of metalloproteinases-1 expression and further contributes to collagen accumulation: From clinical to bench studies
|
Hung C.-S.; Chou C.-H.; Liao C.-W.; Lin Y.-T.; Wu X.-M.; Chang Y.-Y.; Chen Y.-H.; Su M.-J.; Ho Y.-L.; Chen M.-F.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2020-09-28T07:04:37Z |
The relation among aldosterone, galectin-3, and myocardial fibrosis: A prospective clinical pilot follow-up study
|
Liao C.-W.; Lin Y.-T.; Wu X.-M.; Chang Y.-Y.; Hung C.-S.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2020-09-07T06:32:44Z |
Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress
|
Lin Y.-T.; Huang L.-Y.; Huang W.-C.; Lin Y.-C.; TZU-TANG WEI; Wu M.-H.; Lin Y.-C.; Chen C.-C. |
| 臺大學術典藏 |
2020-09-07T06:32:44Z |
Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress
|
Chuang S.-H.; Wu M.-S.; Chen C.-C.; TZU-TANG WEI; Lin S.-H.; Shun C.-T.; Lin Y.-T.; Yang P.-M. |
| 臺大學術典藏 |
2020-09-07T06:32:42Z |
Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer
|
TZU-TANG WEI; Lin Y.-T.; Chen W.-S.; Luo P.; Lin Y.-C.; Chen C.-C.; Liang J.-T.; Tai K.-Y.; Chang L.-C.; Yang K.-C.; Shun C.-T.; Lin Y.-H.; Chen J.-B.; Chen N.-W.; Fang J.-M.; Wu M.-S. |
| 臺大學術典藏 |
2020-09-07T06:32:41Z |
Prevention of colitis and colitis-associated colorectal cancer by a novel polypharmacological histone deacetylase inhibitor
|
TZU-TANG WEI; Lin Y.-T.; Tseng R.-Y.; Shun C.-T.; Lin Y.-C.; Wu M.-S.; Fang J.-M.; Chen C.-C. |
| 臺大學術典藏 |
2020-09-07T06:32:39Z |
Correction: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress (Oncotarget (2019) 10 (3577-3578) DOI: 10.18632/oncotarget.1628)
|
Lin Y.-C.;Wu M.-H.;Tzu-Tang Wei;Lin Y.-C.;Huang W.-C.;Huang L.-Y.;Lin Y.-T.;Chen C.-C.; Lin Y.-C.; Wu M.-H.; TZU-TANG WEI; Lin Y.-C.; Huang W.-C.; Huang L.-Y.; Lin Y.-T.; Chen C.-C. |
| 臺大學術典藏 |
2020-09-07T06:32:38Z |
Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer
|
Tzu-Tang Wei;Lin Y.-T.;Tang S.-P.;Luo C.-K.;Tsai C.-T.;Shun C.-T.;Chen C.-C.; TZU-TANG WEI; Lin Y.-T.; Tang S.-P.; Luo C.-K.; Tsai C.-T.; Shun C.-T.; Chen C.-C. |
| 臺大學術典藏 |
2020-08-18T07:28:24Z |
Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer
|
Yang J.C.-H.; YU-FEN WANG; Lin Y.-T.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:28Z |
Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
|
Chen C.-C.; Fang J.-M.; JIN-YUAN SHIH; Lin Y.-C.; Tseng R.-Y.; Chiu A.-C.; Yeh Y.-H.; Liu C.; Lin Y.-T.; Lin Y.-C.; Chen L.-Y.; Weng C.-H. |
| 臺大學術典藏 |
2020-08-13T06:33:27Z |
Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas
|
Gow C.-H.; Hsieh M.-S.; Lin Y.-T.; Liu Y.-N.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:27Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yang J.C.-H.; Yu C.-J.; JIN-YUAN SHIH; Lin Z.-Z.; Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H. |
| 臺大學術典藏 |
2020-08-13T06:33:26Z |
The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer
|
Lin Y.-T.;Liu Y.-N.;Jin-Yuan Shih; Lin Y.-T.; Liu Y.-N.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:23Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
Wang H.-Y.; Liu Y.-N.; Wu S.-G.; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; JIN-YUAN SHIH; Wang H.-Y.;Liu Y.-N.;Wu S.-G.;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Jin-Yuan Shih |
| 臺大學術典藏 |
2020-08-13T06:33:22Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
JIN-YUAN SHIH; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Tsai T.-H.; Lin Y.-T.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Jin-Yuan Shih |
| 臺大學術典藏 |
2020-08-13T05:24:02Z |
Outcome of untreated lung nodules with histological but no microbiological evidence of tuberculosis 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chung C.-L.; Chen Y.-F.; Lin Y.-T.; JANN-YUAN WANG; Kuo S.-W.; Chen J.-S. |
| 臺大學術典藏 |
2020-08-12T08:25:24Z |
Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer
|
Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; SHANG-GIN WU; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:21Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non-Small-cell Lung Cancer
|
Lin Y.-T.;Liu Y.-N.;Shang-Gin Wu;Yang J.C.-H.;Shih J.-Y.; Lin Y.-T.; Liu Y.-N.; SHANG-GIN WU; Yang J.C.-H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:18Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
Wang H.-Y.;Liu Y.-N.;Shang-Gin Wu;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Shih J.-Y.; Wang H.-Y.; Liu Y.-N.; SHANG-GIN WU; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:17Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
Lin Y.-T.;Tsai T.-H.;Shang-Gin Wu;Liu Y.-N.;Yu C.-J.;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; SHANG-GIN WU; Liu Y.-N.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T07:47:00Z |
Transthoracic Ultrasound Elastography in Pulmonary Lesions and Diseases
|
Lim C.-K.; Chung C.-L.; Lin Y.-T.; Chang C.-H.; Lai Y.-C.; HAO-CHIEN WANG; Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T06:34:19Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU; Lin Y.-T.; Chen J.-S.; Liao W.-Y. |
| 臺大學術典藏 |
2020-08-12T06:34:10Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
Liu Y.-N.; CHONG-JEN YU; Shih J.-Y.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Chong-Jen Yu;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; Wu S.-G. |
| 臺大學術典藏 |
2020-08-12T02:50:37Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yu C.-J.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Hsu C.-L.; CHAO-CHI HO; Liao W.-Y.; Chen J.-S.; Lin Y.-T.; Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Chao-Chi Ho;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J. |
| 臺大學術典藏 |
2020-08-05T00:38:51Z |
Human interleukin-10 genotypes are associated with different precore/core gene mutation patterns in children with chronic hepatitis B virus infection
|
Wu J.-F.;Ni Y.-H.;Lin Y.-T.;Lee T.-J.;Sandy Huey-Jen Hsu;Chen H.-L.;Tsuei D.-J.;Hsu H.-Y.;Chang M.-H.; Wu J.-F.; Ni Y.-H.; Lin Y.-T.; Lee T.-J.; SANDY HUEY-JEN HSU; Chen H.-L.; Tsuei D.-J.; Hsu H.-Y.; Chang M.-H. |
| 臺大學術典藏 |
2020-07-21T06:46:16Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; CHAO-CHI HO; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:14Z |
Diagnosis of mediastinal tuberculous lymphadenitis using endobronchial ultrasound-guided transbronchial needle aspiration with rinse fluid polymerase chain reaction
|
Lin C.-K.; Keng L.-T.; Lim C.-K.; Lin Y.-T.; Lin S.-Y.; Chen L.-Y.; Yao Z.-H.; Chen Y.-H.; CHAO-CHI HO |
| 臺大學術典藏 |
2020-07-21T06:25:14Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
TZU-HSIU TSAI; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Shih J.-Y.; Lin Y.-T.; Lin Y.-T.;Tzu-Hsiu Tsai;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:04Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yu C.-J.; Shih J.-Y.; Yang J.C.-H.; Lin Z.-Z.; Lee J.-H.; Chen K.-Y.; Yang C.-Y.; Hsu C.-L.; Ho C.-C.; WEI-YU LIAO; Chen J.-S.; Lin Y.-T. |
| 臺大學術典藏 |
2020-07-20T05:28:06Z |
Atopic dermatitis, melatonin, and sleep disturbance
|
Chiang B.-L.; Wan K.-S.; Chen C.-A.; Yang Y.-H.; Yu H.-H.; Wang L.-C.; Chang Y.-S.;Chou Y.-T.;Lee J.-H.;Pei-Lin Lee;Dai Y.-S.;Sun C.;Lin Y.-T.;Wang L.-C.;Yu H.-H.;Yang Y.-H.;Chen C.-A.;Wan K.-S.;Chiang B.-L.; Chang Y.-S.; Chou Y.-T.; Lee J.-H.; PEI-LIN LEE; Dai Y.-S.; Sun C.; Lin Y.-T. |
| 臺大學術典藏 |
2020-07-20T05:28:04Z |
Melatonin Supplementation for Children with Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial
|
Chang Y.-S.; Lin M.-H.; Lee J.-H.; PEI-LIN LEE; Dai Y.-S.; Chu K.-H.; Sun C.; Lin Y.-T.; Wang L.-C.; Yu H.-H.; Yang Y.-H.; Chen C.-A.; Wan K.-S.; Chiang B.-L. |
| 臺大學術典藏 |
2020-07-10T08:17:03Z |
Facial and Prosodic Emotion Recognition Deficits Associate with Specific Clusters of Psychotic Symptoms in Schizophrenia
|
Tseng, H.-H.; Chen, S.-H.; Liu, C.-M.; Howes, O.; Huang, Y.-L.; Hsieh, M.H.; Liu, C.-C.; Shan, J.-C.; Lin, Y.-T.; Hwu, H.-G.; Tseng, H.-H.; Chen, S.-H.; Liu, C.-M.; Howes, O.; Huang, Y.-L.; Hsieh, M.H.; Liu, C.-C.; Shan, J.-C.; Lin, Y.-T.; Hwu, H.-G.; SUE-HUEI CHEN |
